Annual report pursuant to Section 13 and 15(d)

Net Loss Per Share (Details) - Schedule of potential common shares

v3.22.4
Net Loss Per Share (Details) - Schedule of potential common shares - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 132,220,971 81,185,664
Conversion of Convertible Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents [1] 25,655,579  
Warrants to Purchase Common Stock and Redeemable Convertible Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents [1] 25,599,889 25,599,889
PSUs, RSUs and Options to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents [1] 63,465,503 38,085,775
Right to Receive Earnout Shares [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 17,500,000 17,500,000
[1] Prior period results have been adjusted to reflect the exchange of Legacy MoneyLion Common Stock for Class A Common Stock at an exchange ratio of approximately 16.4078 in September 2021 as a result of the Business Combination. See Note 3, “Business Combination” for details.